Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter studyJitao Wang, Zhongwei Zhao, Yanna Liu et al.|Hepatology International|2022Cited by 32
Effects of the H <sub>2</sub> -Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected PatientsXiaodong Wang, Richard Bertz, Marta Boffito et al.|AIDS Patient Care and STDs|2011Cited by 18
Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective studyXiaolong Qi, Wenhong Zhang, Jitao Wang et al.|Journal of Medical Virology|2022Cited by 12
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter studyJitao Wang, Zhongwei Zhao, Qiran Zhang et al.|Hepatology International|2023Cited by 5
Effects of the H 2 -Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected PatientsJenny Zhang, Yaoshi Wu, Xiaodong Wang et al.|UNC Libraries|2020Cited by 4